Lipid and Lipoprotein Metabolism
Lipid and lipoprotein metabolism is the area of metabolic medicine that deals with how the body synthesises, transports, stores, and degrades fats and the protein-lipid particles that carry them in blood. It links basic biochemistry — cholesterol synthesis, fatty-acid oxidation, ketone-body formation — to clinical conditions such as the dyslipidaemias and the metabolic syndrome that drive cardiovascular risk.
Definition
Lipid and lipoprotein metabolism encompasses the biochemical pathways that produce, transport, and dispose of cholesterol, triglycerides, fatty acids, and ketone bodies, together with the lipoprotein particles (chylomicrons, VLDL, LDL, HDL) that move these water-insoluble lipids through the circulation, and the disorders that arise when these pathways are disturbed.
Scope
This area orients the reader to the major lipid pathways and their clinical extensions: cholesterol synthesis and transport, the lipoprotein particles and their handling, the dyslipidaemias, fatty-acid oxidation and ketone-body metabolism, and the metabolic syndrome. It frames these as interconnected reference topics within endocrinology and metabolism rather than as a treatment manual.
Sub-topics
Core questions
- How are cholesterol and triglycerides synthesised, packaged into lipoproteins, and delivered to tissues?
- How do the receptor-mediated and reverse-transport pathways keep cholesterol in balance?
- How do disturbances in these pathways produce dyslipidaemias and contribute to cardiovascular risk?
- How does fatty-acid oxidation and ketone-body production supply fuel during fasting?
Key concepts
- Cholesterol homeostasis and the LDL-receptor pathway
- Lipoprotein classes and apolipoproteins
- Reverse cholesterol transport
- Dyslipidaemia and atherogenesis
- Fatty-acid oxidation and ketogenesis
- Metabolic syndrome clustering
Mechanisms
Dietary and endogenously synthesised lipids are assembled into lipoproteins for transport: intestinal chylomicrons and hepatic very-low-density lipoprotein (VLDL) deliver triglycerides to peripheral tissues, and the remnants are processed to low-density lipoprotein (LDL), which is cleared by the LDL receptor in a feedback-controlled pathway described by Brown and Goldstein. High-density lipoprotein (HDL) mediates reverse cholesterol transport from tissues back to the liver. During fasting, fatty acids are mobilised and oxidised, and the liver converts acetyl-CoA to ketone bodies as an alternative fuel. Fredrickson's integrated framework first organised these transport processes and their disorders into a coherent clinical scheme.
Clinical relevance
The pathways in this area underlie much of cardiovascular and metabolic medicine: abnormalities of lipoprotein handling define the dyslipidaemias, and their clustering with insulin resistance, central adiposity, and hypertension defines the metabolic syndrome. This entry describes the biology and clinical associations for reference and education; it is not a basis for individual diagnosis or treatment decisions, which follow current clinical guidelines.
Epidemiology
Disorders of lipid and lipoprotein metabolism are among the most common chronic-disease risk factors worldwide, and elevated LDL cholesterol is a major modifiable contributor to atherosclerotic cardiovascular disease, as reflected in international management guidelines.
Evidence & guidelines
Professional guidelines such as the 2019 ESC/EAS guidelines for the management of dyslipidaemias synthesise the evidence relating lipoprotein levels to cardiovascular risk and frame how lipid pathways are assessed in practice.
History
The modern understanding of this area was built in the twentieth century: Fredrickson and Lees in 1967 produced an integrated account of fat transport and its disorders, and Brown and Goldstein's work on the LDL receptor in the 1970s and 1980s explained cholesterol homeostasis at the molecular level, work recognised with the 1985 Nobel Prize in Physiology or Medicine.
Key figures
- Michael Brown
- Joseph Goldstein
- Donald Fredrickson
- Robert Lees
Related topics
Seminal works
- brown-goldstein-1986
- fredrickson-1967
Frequently asked questions
- Why does the body need lipoproteins?
- Lipids such as cholesterol and triglycerides are not soluble in water, so they must be packaged with proteins into lipoprotein particles to be transported safely through the bloodstream.
- How does this area relate to heart disease?
- Disturbances in lipoprotein handling, especially elevated LDL cholesterol, promote atherosclerosis, which is why lipid metabolism is central to cardiovascular risk and to the metabolic syndrome.